Lee Chan Henry's Form 4 filing
BeOne Medicines Ltd. (ONC) · filed Aug 13, 2026
- Accession no.
- 0001980648-26-000024
- Filed
- Aug 13, 2026, 8:54 PM ET
- Trade date
- Aug 11, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $959.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lee Chan HenryCIK 0001980648 | Officer (SVP, General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2026 | American Depositary Shares | MOption exerciseAcquired | +812 | $194.47 | +$157,909.64 | 812 | Direct | |
| Aug 11, 2026 | American Depositary Shares | MOption exerciseAcquired | +1,058 | $213.32 | +$225,692.56 | 1,870 | Direct | |
| Aug 11, 2026 | American Depositary Shares | MOption exerciseAcquired | +796 | $159.03 | +$126,587.88 | 2,666 | Direct | |
| Aug 11, 2026 | American Depositary Shares | SSaleDisposed | −2,666 | $360.00 | −$959,760 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2026 | Ordinary Shares | MOption exerciseDisposed | −10,556 | $0.00 | $0 | 0 | Direct | |
| Aug 11, 2026 | Ordinary Shares | MOption exerciseDisposed | −13,754 | $0.00 | $0 | 57,369 | Direct | |
| Aug 11, 2026 | Ordinary Shares | MOption exerciseDisposed | −10,348 | $0.00 | $0 | 88,582 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.